These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26899733)

  • 1. Editorial: Effective and Promising Treatments for Neurological Disorders and Cancer.
    Uteshev VV
    Curr Pharm Des; 2016; 22(14):1979-80. PubMed ID: 26899733
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuroprotective Potential of Chrysin: Mechanistic Insights and Therapeutic Potential for Neurological Disorders.
    Mishra A; Mishra PS; Bandopadhyay R; Khurana N; Angelopoulou E; Paudel YN; Piperi C
    Molecules; 2021 Oct; 26(21):. PubMed ID: 34770864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Potential of Oridonin and Its Analogs: From Anticancer and Antiinflammation to Neuroprotection.
    Xu J; Wold EA; Ding Y; Shen Q; Zhou J
    Molecules; 2018 Feb; 23(2):. PubMed ID: 29470395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanotechnology enabled regenerative medicine for neurological disorders.
    Lowe TL; Agrahari V; Kannan RM; Kannan S
    Adv Drug Deliv Rev; 2019 Aug; 148():1-2. PubMed ID: 31787167
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic potential of naringin in neurological disorders.
    Ahmed S; Khan H; Aschner M; Hasan MM; Hassan STS
    Food Chem Toxicol; 2019 Oct; 132():110646. PubMed ID: 31252025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AEOL-10150 (Aeolus).
    Orrell RW
    Curr Opin Investig Drugs; 2006 Jan; 7(1):70-80. PubMed ID: 16425674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotection: lessons from a spectrum of neurological disorders.
    Galpern WR; Singhal AB
    Int J Stroke; 2006 May; 1(2):97-9. PubMed ID: 18706052
    [No Abstract]   [Full Text] [Related]  

  • 8. Monoamine oxidase inhibitors and neuroprotection: a review.
    Al-Nuaimi SK; Mackenzie EM; Baker GB
    Am J Ther; 2012 Nov; 19(6):436-48. PubMed ID: 22960850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress in the discovery and development of glutamate carboxypeptidase II inhibitors.
    Tsukamoto T; Wozniak KM; Slusher BS
    Drug Discov Today; 2007 Sep; 12(17-18):767-76. PubMed ID: 17826690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medicine. A boost for translational neuroscience.
    Ehrenreich H
    Science; 2004 Jul; 305(5681):184-5. PubMed ID: 15247460
    [No Abstract]   [Full Text] [Related]  

  • 11. Neurotensins and their therapeutic potential: research field study.
    Kan Yeung AW; Georgieva MG; Kirilov K; Balacheva AA; Peeva MI; Horbańczuk OK; Horbańczuk JO; Lucarini M; Durazzo A; Santini A; Souto EB; Pajpanova TI; Milella L; Atanasov AG; Tzvetkov NT
    Future Med Chem; 2020 Oct; 12(19):1779-1803. PubMed ID: 33032465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DP-b99 (D-Pharm).
    Yeung PK
    Curr Opin Investig Drugs; 2004 Jan; 5(1):90-4. PubMed ID: 14983980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marine natural product drug discovery: Leads for treatment of inflammation, cancer, infections, and neurological disorders.
    Villa FA; Gerwick L
    Immunopharmacol Immunotoxicol; 2010 Jun; 32(2):228-37. PubMed ID: 20441539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Editorial (Thematic Issue: Hybrid Compounds as Multitarget Agents in Medicinal Chemistry - Part II).
    Scotti L; Mendonça-Junior FJ; Scotti MT
    Curr Top Med Chem; 2017; 17(9):957-958. PubMed ID: 28406075
    [No Abstract]   [Full Text] [Related]  

  • 15. Neurological complications of new chemotherapy agents.
    Zukas AM; Schiff D
    Neuro Oncol; 2018 Jan; 20(1):24-36. PubMed ID: 28992326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The concept of neuroprotection].
    Onténiente B
    Rev Neurol (Paris); 2000 Feb; 156(2):192-4. PubMed ID: 10743023
    [No Abstract]   [Full Text] [Related]  

  • 17. Enabling biodegradable functional biomaterials for the management of neurological disorders.
    Shan D; Ma C; Yang J
    Adv Drug Deliv Rev; 2019 Aug; 148():219-238. PubMed ID: 31228483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging indications for statins: a pluripotent family of agents with several potential applications.
    Paraskevas KI; Tzovaras AA; Briana DD; Mikhailidis DP
    Curr Pharm Des; 2007; 13(35):3622-36. PubMed ID: 18220799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editorial: Biological Profiles of Coumarin Scaffold - Part 1.
    de Carvalho da Silva F; Ferreira VF; da Silva Magalhaes Forezi L
    Curr Top Med Chem; 2017; 17(29):3171-3172. PubMed ID: 29475429
    [No Abstract]   [Full Text] [Related]  

  • 20. Neramexane (merz pharmaceuticals/forest laboratories).
    Rammes G; Schierloh A
    IDrugs; 2006 Feb; 9(2):128-35. PubMed ID: 16523403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.